Annexin A2 mediates mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells

mBio

Volumn 5, Issue 4, 2014, Pages

  Somarajan, Sudha R ^a,b   Al Asadi, Fadi ^a   Ramasamy, Kumaraguruparan ^a   Pandranki, Lavanya ^a   Baseman, Joel B ^a   Kannan, T R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; CYTOTOXIN; LIPOCORTIN 2; UNCLASSIFIED DRUG; ANXA2 PROTEIN, HUMAN; BACTERIAL PROTEIN; BACTERIAL TOXIN; CARDS TOXIN, MYCOPLASMA PNEUMONIAE; MONOCLONAL ANTIBODY; PROTEIN BINDING; SMALL INTERFERING RNA;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL VACUOLE; CONTROLLED STUDY; EUKARYOTIC CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTERNALIZATION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TIME OF FLIGHT MASS SPECTROMETRY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MYCOPLASMA PNEUMONIAE; TUMOR CELL LINE; ULTRASTRUCTURE;

EUKARYOTA; MYCOPLASMA PNEUMONIAE;

ANIMALS; ANNEXIN A2; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE, TUMOR; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; HEP G2 CELLS; HUMANS; MYCOPLASMA PNEUMONIAE; PROTEIN BINDING; RESPIRATORY DISTRESS SYNDROME, ADULT; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VACUOLES;

EID: 84908263133     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01497-14     Document Type: Article

References (51)

1. Baseman JB, Tully JG. 1997. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis. 3:21-32. http://dx.doi.org/10.3201/eid0301.970103.
2. Kraft M, Cassell GH, Pak J, Martin RJ. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121:1782-1788. http://dx.doi.org/10.1378/chest.121.6.1782.
3. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, Iniguez JL, Chaussain M, Nicand E, Raymond J, Gendrel D. 2004. Mycoplasma pneumoniae and asthma in children. Clin. Infect. Dis. 38:1341-1346. http://dx.doi.org/10.1086/392498.
4. Waites KB, Talkington DF. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728. http://dx.doi.org/10.1128/CMR.17.4.697-728.2004.
5. Nisar N, Guleria R, Kumar S, Chand Chawla T, Ranjan Biswas N. 2007. Mycoplasma pneumoniae and its role in asthma. Postgrad. Med. J. 83: 100-104. http://dx.doi.org/10.1136/pgmj.2006.049023.
6. Atkinson TP, Balish MF, Waites KB. 2008. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol. Rev. 32:956-973. http://dx.doi.org/10.1111/j.1574-6976.2008.00129.x.
7. Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, Coalson JJ, Baseman JG, Cagle M, Baseman JB. 2011. Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 140:401-407. http://dx.doi.org/10.1378/chest.11-0221.
8. Baseman JB. 1993. The cytadhesins of Mycoplasma pneumoniae and M. genitalium. Subcell. Biochem. 20:243-259. http://dx.doi.org/10.1007/978-1-4615-2924-8_9.
9. Krause DC, Balish MF. 2001. Structure, function, and assembly of the terminal organelle of Mycoplasma pneumoniae. FEMS Microbiol. Lett. 198:1-7. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10610.x.
10. Tyron VV, Baseman JB. 1992. Pathogenic determinants and mechanisms, p 457-471. In Maniloff J, McElhaney RN, Finch LR, Baseman JB (ed), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, DC.
11. Somerson NL, Walls BE, Chanock RM. 1965. Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide. Science 150:226-228. http://dx.doi.org/10.1126/science.150.3693.226.
12. Cohen G, Somerson NL. 1967. Mycoplasma pneumoniae: hydrogen peroxide secretion and its possible role in virulence. Ann. N. Y. Acad. Sci. 143:85-87. http://dx.doi.org/10.1111/j.1749-6632.1967.tb27648.x.
13. Lynch RE, Cole BC. 1980. Mycoplasma pneumoniae: a prokaryote which consumes oxygen and generates superoxide but which lacks superoxide dismutase. Biochem. Biophys. Res. Commun. 96:98-105. http://dx.doi.org/10.1016/0006-291X(80)91186-9.
14. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. 2002. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 121: 1493-1497. http://dx.doi.org/10.1378/chest.121.5.1493.
15. Yang J, Hooper WC, Phillips DJ, Talkington DF. 2004. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev. 15: 157-168. http://dx.doi.org/10.1016/j.cytogfr.2004.01.001.
16. Kannan TR, Baseman JB. 2006. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 103: 6724-6729. http://dx.doi.org/10.1073/pnas.0510644103.
17. Kannan TR, Provenzano D, Wright JR, Baseman JB. 2005. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect. Immun. 73:2828-2834. http://dx.doi.org/10.1128/IAI.73.5.2828-2834.2005.
18. Kannan TR, Coalson JJ, Cagle M, Musatovova O, Hardy RD, Baseman JB. 2011. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model. J. Infect. Dis. 204:1596-1604. http://dx.doi.org/10.1093/infdis/jir557.
19. Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, Krunkosky TM, Davis A, Hardy RD, Baseman JB. 2010. Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol. Microbiol. 76:1127-1141. http://dx.doi.org/10.1111/j.1365-2958.2010.07092.x.
20. Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. 2009. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 4:e7562. http://dx.doi.org/10.1371/journal.pone.0007562.
21. Medina JL, Coalson JJ, Brooks EG, Winter VT, Chaparro A, Principe MF, Kannan TR, Baseman JB, Dube PH. 2012. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am. J. Respir. Cell Mol. Biol. 46:815-822. http://dx.doi.org/10.1165/rcmb.2011-0135OC.
22. Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, Coalson JJ, Baseman JB, Hardy RD. 2010. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am. J. Respir. Crit. Care Med. 182:797-804. http://dx.doi.org/10.1164/rccm.201001-0080OC.
23. Krishnan M, Kannan TR, Baseman JB. 2013. Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis. PLoS One 8:e62706. http://dx.doi.org/10.1371/journal.pone.0062706.
24. Johnson C, Kannan TR, Baseman JB. 2011. Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments. PLoS One 6:e22877. http://dx.doi.org/10.1371/journal.pone.0022877.
25. Mekada E, Okada Y, Uchida T. 1988. Identification of diphtheria toxin receptor and a nonproteinous diphtheria toxin-binding molecule in Vero cell membrane. J. Cell Biol. 107:511-519. http://dx.doi.org/10.1083/jcb.107.2.511.
26. Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, Kozaki S. 1994. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269:10498-10503.
27. Cowell S, Aschauer W, Gruber HJ, Nelson KL, Buckley JT. 1997. The erythrocyte receptor for the channel-forming toxin aerolysin is a novel glycosylphosphatidylinositol-anchored protein. Mol. Microbiol. 25: 343-350. http://dx.doi.org/10.1046/j.1365-2958.1997.4691828.x.
28. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. 2002. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol. Microbiol. 46:1041-1051. http://dx.doi.org/10.1046/j.1365-2958.2002.03207.x.
29. Nelson KL, Raja SM, Buckley JT. 1997. The glycosylphosphatidylinositol-anchored surface glycoprotein Thy-1 is a receptor for the channel-forming toxin aerolysin. J. Biol. Chem. 272:12170-12174. http://dx.doi.org/10.1074/jbc.272.18.12170.
30. Kannan TR, Krishnan M, Ramasamy K, Becker A, Pakhomova ON, Hart PJ, Baseman JB. 20 June 2014. Functional mapping of community acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating, and receptor-binding activities. Mol. Microbiol. http://dx.doi.org/10.1111/mmi.12680.
31. Gerke V, Moss SE. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371.
32. Filipenko NR, Waisman DM. 2001. The C terminus of annexin II mediates binding to F-actin. J. Biol. Chem. 276:5310-5315. http://dx.doi.org/10.1074/jbc.M009710200.
33. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J. 1996. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2. J. Biol. Chem. 271:21652-21659. http://dx.doi.org/10.1074/jbc.271.35.21652.
34. Peterson EA, Sutherland MR, Nesheim ME, Pryzdial EL. 2003. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J. Cell Sci. 116:2399-2408. http://dx.doi.org/10.1242/jcs.00434.
35. Fan X, Krahling S, Smith D, Williamson P, Schlegel RA. 2004. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol. Biol. Cell 15:2863-2872. http://dx.doi.org/10.1091/mbc.E03-09-0670.
36. Law AL, Ling Q, Hajjar KA, Futter CE, Greenwood J, Adamson P, Wavre-Shapton ST, Moss SE, Hayes MJ. 2009. Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Mol. Biol. Cell 20:3896-3904. http://dx.doi.org/10.1091/mbc.E08-12-1204.
37. Fang YT, Lin CF, Wang CY, Anderson R, Lin YS. 2012. Interferongamma stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis. J. Cell. Physiol. 227: 2775-2787. http://dx.doi.org/10.1002/jcp.23026.
38. Lee DB, Jamgotchian N, Allen SG, Kan FW, Hale IL. 2004. Annexin A2 heterotetramer: role in tight junction assembly. Am. J. Physiol. Renal Physiol. 287:F481-F491. http://dx.doi.org/10.1152/ajprenal.00175.2003.
39. Kirschnek S, Adams C, Gulbins E. 2005. Annexin II is a novel receptor for Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 327: 900-906. http://dx.doi.org/10.1016/j.bbrc.2004.12.089.
40. Jolly C, Winfree S, Hansen B, Steele-Mortimer O. 2014. The annexin A2/p11 complex is required for efficient invasion of Salmonella typhimurium in epithelial cells. Cell. Microbiol. 16:64-77. http://dx.doi.org/10.1111/cmi.12180.
41. Munera D, Martinez E, Varyukhina S, Mahajan A, Ayala-Sanmartin J, Frankel G. 2012. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli. Biochem. J. 445:383-392. http://dx.doi.org/10.1042/BJ20120533.
42. Wright JF, Kurosky A, Wasi S. 1994. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198:983-989. http://dx.doi.org/10.1006/bbrc.1994.1140.
43. LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Péchoux C, Delmas B, Riteau B. 2008. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J. Virol. 82:6820-6828. http://dx.doi.org/10.1128/JVI.00246-08.
44. Ryzhova EV, Vos RM, Albright AV, Harrist AV, Harvey T, González-Scarano F. 2006. Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J. Virol. 80:2694-2704. http://dx.doi.org/10.1128/JVI.80.6.2694-2704.2006.
45. Harrist AV, Ryzhova EV, Harvey T, González-Scarano F. 2009. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphatecontaining lipid rafts and increases viral production in 293T cells. PLoS One 4:e5020. http://dx.doi.org/10.1371/journal.pone.0005020.
46. Backes P, Quinkert D, Reiss S, Binder M, Zayas M, Rescher U, Gerke V, Bartenschlager R, Lohmann V. 2010. Role of annexin A2 in the production of infectious hepatitis C virus particles. J. Virol. 84:5775-5789. http://dx.doi.org/10.1128/JVI.02343-09.
47. Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 85: 11809-11820. http://dx.doi.org/10.1128/JVI.00297-11.
48. Turpin E, Russo-Marie F, Dubois T, de Paillerets C, Alfsen A, Bomsel M. 1998. In adrenocortical tissue, annexins II and VI are attached to clathrin coated vesicles in a calcium-independent manner. Biochim. Biophys. Acta 1402:115-130. http://dx.doi.org/10.1016/S0167-4889(97)00151-1.
49. Schnitzer JE, Liu J, Oh P. 1995. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J. Biol. Chem. 270: 14399-14404.
50. Merrifield CJ, Rescher U, Almers W, Proust J, Gerke V, Sechi AS, Moss SE. 2001. Annexin 2 has an essential role in actin-based macropinocytic rocketing. Curr. Biol. 11:1136-1141. http://dx.doi.org/10.1016/S0960-9822(01)00321-9.
51. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-1572. http://dx.doi.org/10.1038/nbt1037.